Successful isolation and expansion of CMV-reactive T cells from G-CSF mobilized donors that retain a strong cytotoxic effector function

British Journal of Haematology

Volumn 160, Issue 1, 2013, Pages 87-100

  Samuel, Edward R ^a   Newton, Katy ^a,b   MacKinnon, Stephen ^a   Lowdell, Mark W ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Cell Medica Ltd   (United Kingdom)

^c ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

CD154; Cytomegalovirus specific T cells; Granulocyte colony stimulating factor mobilization; Haematopoietic stem cell transplantation; Immunotherapy

Indexed keywords

CD40 LIGAND; CYTOMEGALOVIRUS ANTIGEN PP65; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL EXPANSION; CELL ISOLATION; CELL PROLIFERATION; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; STEM CELL MOBILIZATION;

CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LEUKOCYTES, MONONUCLEAR; PHOSPHOPROTEINS; T-LYMPHOCYTES; VIRAL MATRIX PROTEINS;

EID: 84870771100     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12082     Document Type: Article

References (41)

1. + CTLs ex vivo. The Journal of Immunology, 168, 5954-5958.
2. Arpinati, M., Green, C.L., Heimfeld, S., Heuser, J.E. & Anasetti, C. (2000) Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood, 95, 2484-2490.
3. Brines, R.D. & Klaus, G.G. (1993) Polyclonal activation of immature B cells by preactivated T cells: the role of IL-4 and CD40 ligand. International Immunology, 5, 1445-1450.
4. Chakrabarti, S., Mackinnon, S., Chopra, R., Kottaridis, P.D., Peggs, K., O'Gorman, P., Chakraverty, R., Marshall, T., Osman, H., Mahendra, P., Craddock, C., Waldmann, H., Hale, G., Fegan, C.D., Yong, K., Goldstone, A.H., Linch, D.C. & Milligan, D.W. (2002) High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood, 99, 4357-4363.
5. + T cells with diverse cytokine profiles. Nature Medicine, 11, 1113-1117.
6. Cobbold, M., Khan, N., Pourgheysari, B., Tauro, S., McDonald, D., Osman, H., Assenmacher, M., Billingham, L., Steward, C., Crawley, C., Olavarria, E., Goldman, J., Chakraverty, R., Mahendra, P., Craddock, C. & Moss, P.A. (2005) Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. Journal of Experimental Medicine, 202, 379-386.
7. Einsele, H., Ehninger, G., Hebart, H., Wittkowski, K.M., Schuler, U., Jahn, G., Mackes, P., Herter, M., Klingebiel, T., Loffler, J., Wagner, S. & Muller, C.A. (1995) Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood, 86, 2815-2820.
8. Einsele, H., Roosnek, E., Rufer, N., Sinzger, C., Riegler, S., Loffler, J., Grigoleit, U., Moris, A., Rammensee, H.G., Kanz, L., Kleihauer, A., Frank, F., Jahn, G. & Hebart, H. (2002) Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood, 99, 3916-3922.
9. + T cells specific for defined antigens according to CD154 expression. Nature Medicine, 11, 1118-1124.
10. + cytomegalovirus phosphoprotein pp65 epitope determination. The Journal of Immunology, 167, 4196-4206.
11. Goodrich, J.M., Bowden, R.A., Fisher, L., Keller, C., Schoch, G. & Meyers, J.D. (1993) Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Annals of Internal Medicine, 118, 173-178.
12. Gooley, T.A., Chien, J.W., Pergam, S.A., Hingorani, S., Sorror, M.L., Boeckh, M., Martin, P.J., Sandmaier, B.M., Marr, K.A., Appelbaum, F.R., Storb, R. & McDonald, G.B. (2010) Reduced mortality after allogeneic hematopoietic-cell transplantation. New England Journal of Medicine, 363, 2091-2101.
13. + T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations. Cytometry Part B: Clinical Cytometry, 74, 211-220.
14. Hartung, T., Doecke, W.D., Bundschuh, D., Foote, M.A., Gantner, F., Hermann, C., Lenz, A., Milwee, S., Rich, B., Simon, B., Volk, H.D., von Aulock, S. & Wendel, A. (1999) Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions. Clinical Pharmacology and Therapeutics, 66, 415-424.
15. Khanna, N., Stuehler, C., Conrad, B., Lurati, S., Krappmann, S., Einsele, H., Berges, C. & Topp, M.S. (2011) Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154. Blood, 118, 1121-1131.
16. Leen, A.M., Myers, G.D., Sili, U., Huls, M.H., Weiss, H., Leung, K.S., Carrum, G., Krance, R.A., Chang, C.C., Molldrem, J.J., Gee, A.P., Brenner, M.K., Heslop, H.E., Rooney, C.M. & Bollard, C.M. (2006) Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nature Medicine, 12, 1160-1166.
17. Levine, J.E., Braun, T., Penza, S.L., Beatty, P., Cornetta, K., Martino, R., Drobyski, W.R., Barrett, A.J., Porter, D.L., Giralt, S., Leis, J., Holmes, H.E., Johnson, M., Horowitz, M. & Collins, Jr, R.H. (2002) Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation. Journal of Clinical Oncology, 20, 405-412.
18. Lugthart, G., Albon, S.J., Ricciardelli, I., Kester, M.G., Meij, P., Lankester, A.C. & Amrolia, P.J. (2012) Simultaneous generation of multivirus-specific and regulatory T cells for adoptive immunotherapy. Journal of Immunotherapy, 35, 42-53.
19. Mackinnon, S., Thomson, K., Verfuerth, S., Peggs, K. & Lowdell, M. (2008) Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells. Blood Cells, Molecules, and Diseases, 40, 63-67.
20. Micklethwaite, K., Hansen, A., Foster, A., Snape, E., Antonenas, V., Sartor, M., Shaw, P., Bradstock, K. & Gottlieb, D. (2007) Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 13, 707-714.
21. Morris, E.S., MacDonald, K.P., Rowe, V., Johnson, D.H., Banovic, T., Clouston, A.D. & Hill, G.R. (2004) Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood, 103, 3573-3581.
22. Neri, S., Mariani, E., Meneghetti, A., Cattini, L. & Facchini, A. (2001) Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants. Clinical Diagnostic Laboratory Immunology, 8, 1131-1135.
23. Otto, M., Barfield, R.C., Iyengar, R., Gatewood, J., Muller, I., Holladay, M.S., Houston, J., Leung, W. & Handgretinger, R. (2005) Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation. Journal of Immunotherapy, 28, 73-78.
24. Pan, L., Teshima, T., Hill, G.R., Bungard, D., Brinson, Y.S., Reddy, V.S., Cooke, K.R. & Ferrara, J.L. (1999) Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. Blood, 93, 4071-4078.
25. Peggs, K.S. (2009) Adoptive T cell immunotherapy for cytomegalovirus. Expert Opinion on Biological Therapy, 9, 725-736.
26. Peggs, K.S., Verfuerth, S., Pizzey, A., Khan, N., Guiver, M., Moss, P.A. & Mackinnon, S. (2003) Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet, 362, 1375-1377.
27. Peggs, K.S., Thomson, K., Samuel, E., Dyer, G., Armoogum, J., Chakraverty, R., Pang, K., Mackinnon, S. & Lowdell, M.W. (2011) Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation. Clinical Infectious Diseases, 52, 49-57.
28. Perruccio, K., Tosti, A., Burchielli, E., Topini, F., Ruggeri, L., Carotti, A., Capanni, M., Urbani, E., Mancusi, A., Aversa, F., Martelli, M.F., Romani, L. & Velardi, A. (2005) Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood, 106, 4397-4406.
29. + regulatory T cells from patient leukapheresis samples. Journal of Immunotherapy, 28, 403-411.
30. Reusser, P., Riddell, S.R., Meyers, J.D. & Greenberg, P.D. (1991) Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood, 78, 1373-1380.
31. Riddell, S.R., Watanabe, K.S., Goodrich, J.M., Li, C.R., Agha, M.E. & Greenberg, P.D. (1992) Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science, 257, 238-241.
32. Rutella, S., Rumi, C., Testa, U., Sica, S., Teofili, L., Martucci, R., Peschle, C. & Leone, G. (1997) Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): possible role of lactoferrin and interleukin-1 receptor antagonist. Bone Marrow Transplantation, 20, 355-364.
33. Sica, S., Rutella, S., Di, M.A., Salutari, P., Rumi, C., Ortu la, B.E., Etuk, B., Menichella, G., D'Onofrio, G. & Leone, G. (1996) rhG-CSF in healthy donors: mobilization of peripheral hemopoietic progenitors and effect on peripheral blood leukocytes. Journal of Hematotherapy, 5, 391-397.
34. Slezak, S.L., Bettinotti, M., Selleri, S., Adams, S., Marincola, F.M. & Stroncek, D.F. (2007) CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects. Journal of Translational Medicine, 5, 17.
35. Tayebi, H., Kuttler, F., Saas, P., Lienard, A., Petracca, B., Lapierre, V., Ferrand, C., Fest, T., Cahn, J., Blaise, D., Kuentz, M., Herve, P., Tiberghien, P. & Robinet, E. (2001) Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells. Experimental Hematology, 29, 458-470.
36. Walter, E.A., Greenberg, P.D., Gilbert, M.J., Finch, R.J., Watanabe, K.S., Thomas, E.D. & Riddell, S.R. (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. New England Journal of Medicine, 333, 1038-1044.
37. Watanabe, K., Suzuki, S., Kamei, M., Toji, S., Kawase, T., Takahashi, T., Kuzushima, K. & Akatsuka, Y. (2008) CD137-guided isolation and expansion of antigen-specific CD8 cells for potential use in adoptive immunotherapy. International Journal of Hematology, 88, 311-320.
38. + T cells based on antigen-triggered CD137 expression. Journal of Immunological Methods, 339, 23-37.
39. + T cells responding to antigen without requiring knowledge of epitope specificities. Blood, 110, 201-210.
40. + T cells for adoptive immunotherapy. Journal of Immunotherapy, 32, 513-523.
41. + T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy. Cytotherapy, 12, 933-944.